4
Changes in Ownership
Edwards Lifesciences Corp Filed Acc 0001225208-26-006576
CVP, TAVR sold 619 shares at $91.70 ($56,762)
- CVP, TAVR acquired 619 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lippis Daniel J. CVP, TAVR | 2026-07-10 | Option exercise 10b5-1 | +619 | $72.68 | $44,989 | 40,652.91 | D: show line 1 in the form |
| Lippis Daniel J. CVP, TAVR | 2026-07-10 | Sale 10b5-1 | −619 | $91.70 | $56,762 | 40,033.91 | D: show line 2 in the form |
| Open-market sales · 619 sh · avg $91.70 · $56,762 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Lippis Daniel J. CVP, TAVR | 2026-07-10 | Option exercise · Employee Stock Option (Right to Acquire) 10b5-1 | −619 | 4,952 | D: show line 3 in the form |
Loading xslF345X06/doc4.xml…